info@synchemia.com | sales@synchemia.com 
9766925136 
Gliclazide EP Impurity B
_1.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gliclazide is used to treat type 2 diabetes. It's a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.N-Nitroso Gliclazide EP Impurity B is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gliclazide EP Impurity B chemically represented as 2-Nitroso octahydrocyclopenta[c]pyrrole. Synchemia is the leading manufacturing and exporter of N-Nitroso Gliclazide EP Impurity B.We supply N-Nitroso Gliclazide EP Impurity B with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0144019 |
| CAS No | NA |
| Mol.F. | C21H22N2O5S |
| Mol.Wt. | 414.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144020 |
| CAS No | NA |
| Mol.F. | C12H14N2O4S |
| Mol.Wt. | 282.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144021 |
| CAS No | NA |
| Mol.F. | C14H16N2O5S |
| Mol.Wt. | 324.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144022 |
| CAS No | NA |
| Mol.F. | C24H27N3O7S2 |
| Mol.Wt. | 533.61 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144023 |
| CAS No | NA |
| Mol.F. | C19H20N2O4S |
| Mol.Wt. | 372.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144024 |
| CAS No | NA |
| Mol.F. | C38H39N3O7S2 |
| Mol.Wt. | 713.86 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144025 |
| CAS No | NA |
| Mol.F. | C19H18N2O4 |
| Mol.Wt. | 338.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144026 |
| CAS No | NA |
| Mol.F. | C13H16N2O4S |
| Mol.Wt. | 296.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144027 |
| CAS No | NA |
| Mol.F. | C15H18N2O5S |
| Mol.Wt. | 338.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144028 |
| CAS No | NA |
| Mol.F. | C21H22N2O6S |
| Mol.Wt. | 430.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144029 |
| CAS No | NA |
| Mol.F. | C19H10Cl2I2N2O4 |
| Mol.Wt. | 655.01 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144030 |
| CAS No | NA |
| Mol.F. | C18H22N2O4 |
| Mol.Wt. | 330.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144031 |
| CAS No | NA |
| Mol.F. | C18H22N2O3 |
| Mol.Wt. | 314.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144032 |
| CAS No | NA |
| Mol.F. | C18H19D3N2O4 |
| Mol.Wt. | 333.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144033 |
| CAS No | NA |
| Mol.F. | C20H22FN5O7 |
| Mol.Wt. | 463.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144034 |
| CAS No | NA |
| Mol.F. | C19H20FN5O7 |
| Mol.Wt. | 449.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
